Blaire Rikard

Blaire Rikard

Auto-generated profile, based on publicly available information

Blaire Rikard

Duke University School of Medicine, Durham, NC 27710 (B.K.R., J.G.M.); Department of Radiology, Duke University Medical Center, Durham, NC 27710 (B.K.R., J.G.M.); Mass General Brigham Medical Extended Reality Lab, Mass General Brigham, Boston, MA 02114 (B.K.R., R.N.U.).

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 June 2024 in Journal of the American College of Radiology
Verified
Journal Article
Closed access
Min LangMin Lang
Min Lang
SGSamir Ghandour
Samir Ghandour
BRBlaire Rikard
Blaire Rikard
EBEleni K. Balasalle
Eleni K. Balasalle
MRMohammad R. Rouhezamin
Mohammad R. Rouhezamin
RURaul N. Uppot
Raul N. Uppot

4 June 2021 in Brain Communications
Verified
Journal Article
Open access
PDF file
JUJulie Uchitel
Julie Uchitel
KWKeri Wallace
Keri Wallace
LTLinh Tran
Linh Tran
TATavis Abrahamsen
Tavis Abrahamsen
AHArsen Hunanyan
Arsen Hunanyan
MMMohamad A Mikati
Mohamad A Mikati
Alternating hemiplegia of childhood is a rare neurodevelopmental disorder caused by ATP1A3 mutations. Some evidence for disease progression exists, but there are few systematic analyses. Here, we evaluate alternating hemiplegia of childhood progression in humans and in the D801N knock-in alternating hemiplegia of childhood mouse, Mashlool, model. This study performed an ambidirectional (prospective and retrospective data) analysis of an alternating hemiplegia of childhood patient cohort (n = 42, age 10.24 ± 1.48 years) seen at one US centre. To investigate potential disease progression, we used linear mixed effects models incorporating early and subsequent visits, and Wilcoxon Signed Rank test comparing first and last visits. Potential early-life clinical predictors were determined via multivariable regression. We also compared EEG background at first encounter and at last follow-up. We then performed a retrospective confirmation study on a multicentre cohort of alternating hemiplegia of childhood patients from France (n = 52). To investigate disease progression in the Mashlool mouse, we performed behavioural testing on a cohort of Mashlool- mice at prepubescent and adult ages (n = 11). Results: US patients, over time, demonstrated mild worsening of non-paroxysmal disability index scores, but not of paroxysmal disability index scores. Increasing age was a predictor of worse scores: P < 0.0001 for the non-paroxysmal disability index, intellectual disability scale and gross motor scores. Earliest non-paroxysmal disability index score was a predictor of last visit non-paroxysmal disability index score (P = 0.022), and earliest intellectual disability score was a predictor of last intellectual disability score (P = 0.035). More patients with EEG background slowing were noted at last follow-up as compared to initial (P = 0.015). Similar worsening of disease with age was also noted in the French cohort: age was a significant predictor of non-paroxysmal disability index score (P = 0.001) and first and last non-paroxysmal disability index score scores significantly differed (P = 0.002). In animal studies, adult Mashlool mice had, as compared to younger Mashlool mice, (i) worse balance beam performance; (ii) wider base of support; (iii) higher severity of seizures and resultant mortality; and (iv) no increased predisposition to hemiplegic or dystonic spells. In conclusion, (i) non-paroxysmal alternating hemiplegia of childhood manifestations show, on average over time, progression associated with severity of early-life non-paroxysmal disability and age. (ii) Progression also occurs in Mashlool mice, confirming that ATP1A3 disease can lead to age-related worsening. (iii) Clinical findings provide a basis for counselling patients and for designing therapeutic trials. Animal findings confirm a mouse model for investigation of underlying mechanisms of disease progression, and are also consistent with known mechanisms of ATP1A3-related neurodegeneration.

3 August 2023 in Cell Stem Cell
Verified
Journal Article
Closed access
ACAgnes S. Chao
Agnes S. Chao
PMPavle Matak
Pavle Matak
KPKelly Pegram
Kelly Pegram
JPJames Powers
James Powers
CHCollin Hutson
Collin Hutson
EBEric J. Benner
Eric J. Benner

21 January 2024 in Current Problems in Diagnostic Radiology
Verified
Journal Article
Closed access
BRBlaire K. Rikard
Blaire K. Rikard
RFRobert J. French
Robert J. French
JMJonathan G. Martin
Jonathan G. Martin

27 October 2025 in Academic Radiology
Verified
Journal Article
Closed access
BRBlaire K. Rikard
Blaire K. Rikard
DWDavid N. Williams
David N. Williams
KDKate Donovan
Kate Donovan
IDIvan Dimov
Ivan Dimov
MNMinh-Thuy Nguyen
Minh-Thuy Nguyen
RURaul N. Uppot
Raul N. Uppot

22 January 2026 in Medical Education
Verified
Journal Article
Closed access
Ami KobayashiAmi Kobayashi
Ami Kobayashi
JLJulianna Lau
Julianna Lau
BRBlaire Rikard
Blaire Rikard
YMYulia Murray
Yulia Murray
JPJennifer L. Prisco
Jennifer L. Prisco
KMKelsey Miller
Kelsey Miller